Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight
Authors:
- Susan AjaSASusan Aja
- Leslie E. LandreeLLLeslie E. Landree
- Amy M. KlemanAKAmy M. Kleman
- Susan M. MedghalchiSMSusan M. Medghalchi
- Aravinda VadlamudiAVAravinda Vadlamudi
- Jill M. McFaddenJMJill M. McFadden
- Andrea AplascaAAAndrea Aplasca
- Jayson HyunJHJayson Hyun
- Erica PlummerEPErica Plummer
- Khadija DanielsKDKhadija Daniels
- Matthew KemmMKMatthew Kemm
- Craig A. TownsendCTCraig A. Townsend
- 1 February 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 294 (2) , R352-R361
Abstract
Inhibition of brain carnitine palmitoyl-transferase-1 (CPT-1) is reported to decrease food intake and body weight in rats. Yet, the fatty acid synthase (FAS) inhibitor and CPT-1 stimulator C75 produces hypophagia and weight loss when given to rodents intracerebroventricularly (icv). Thus roles and relative contributions of altered brain CPT-1 activity and fatty acid oxidation in these phenomena remain unclarified. We administered compounds that target FAS or CPT-1 to mice by single icv bolus and examined acute and prolonged effects on feeding and body weight. C75 decreased food intake rapidly and potently at all doses (1–56 nmol) and dose dependently inhibited intake on day 1. Dose-dependent weight loss on day 1 persisted through 4 days of postinjection monitoring. The FAS inhibitor cerulenin produced dose-dependent (560 nmol) hypophagia for 1 day, weight loss for 2 days, and weight regain to vehicle control by day 3. The CPT-1 inhibitor etomoxir (32, 320 nmol) did not alter overall day 1 feeding. However, etomoxir attenuated the hypophagia produced by C75, indicating that CPT-1 stimulation is important for C75's effect. A novel compound, C89b, was characterized in vitro as a selective stimulator of CPT-1 that does not affect fatty acid synthesis. C89b (100, 320 nmol) decreased feeding in mice for 3 days and produced persistent weight loss for 6 days without producing conditioned taste aversion. Similarly, intraperitoneal administration decreased feeding and body weight without producing conditioned taste aversion. These results suggest a role for brain CPT-1 in the regulation of energy balance and implicate CPT-1 stimulation as a pharmacological approach to weight loss.Keywords
This publication has 49 references indexed in Scilit:
- Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: Role of PGC-1αProceedings of the National Academy of Sciences, 2006
- Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Novel Effect of C75 on Carnitine Palmitoyltransferase I Activity and Palmitate OxidationBiochemistry, 2006
- Retinal Vessel Diameters and Obesity: A Population‐Based Study in Older PersonsObesity, 2006
- Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscleProceedings of the National Academy of Sciences, 2005
- Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in ratsDiabetologia, 2004
- AMP-activated Protein Kinase Plays a Role in the Control of Food IntakeJournal of Biological Chemistry, 2004
- Long-Chain CoA esters activate human pancreatic beta-cell K ATP channels: potential role in Type 2 diabetesDiabetologia, 2004
- Prolonged Inhibition of Muscle Carnitine Palmitoyltransferase-1 Promotes Intramyocellular Lipid Accumulation and Insulin Resistance in RatsDiabetes, 2001
- Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1998